One year extension for RADAR-AD
On 17 May, the RADAR-AD consortium was granted a one-year extension to make up for
RADAR-AD
Neuronet hosts meetings of its Patient Privacy & Ethics and Data Sharing working groups
Neuronet is an Innovative Medicines Initiative (IMI)-funded coordination and support action, designed to support and
The third annual RADAR-AD consortium meeting gathers over 50 project members
Once a year, RADAR-AD project members from different work streams, patient representatives and scientific advisors
Neuronet publishes series of project introduction videos during Brain Awareness Week
The Neuronet programme launched a series of short introduction videos of the various Innovative Medicines
Neuronet convenes annual event on European research collaboration in Alzheimer’s disease & beyond
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together
RADAR-AD smart home study kicks off on the 25th of November
The first participant in the RADAR-AD tier 3 study was included on the 25th of
Neuronet launches its social media campaign “Programme impact analysis – where we are and where we need to go”
The Neuronet project is setting up an efficient platform to boost collaboration across research projects
RADAR-AD includes 100th participant in the clinical study
On the 22nd of October the RADAR-AD participating clinical center in Stavanger (Norway) included the
Learnings from involving people with dementia, mild cognitive impairment & carers
On 7 October, the funder of the RADAR-AD project – the Innovative Medicines Initiative (IMI),
Start of the RADAR-AD tier 2 study – technologies installed in participants’ homes
The RADAR-AD sub-study (tier 2) is a multicentre, observational digital assessment study among participants with